Kalpataru Multiplier Ltd.

Our Bank & DP Click for Online Payment MF portfolio login smart way to invest in gold
Sovereign gold bond(SGB) Exchange trades funds(ETF)
CLOSE

Download our app Kalpataru Share trading from Google/App Store and transfer fund instantly.

Company Profile
more from company profile
HomeMarkets Company Profile Smart Quotes

Smart Quotes

SENORES PHARMACEUTICALS LTD.

NSE : SENORESBSE : 544319ISIN CODE : INE0RB801010Industry : Pharmaceuticals & DrugsHouse : Private
BSE1517.753.1 (+0.2 %)
PREV CLOSE () 1514.65
OPEN PRICE () 1520.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 30302
TODAY'S LOW / HIGH ()1493.50 1599.55
52 WK LOW / HIGH ()661.65 1576
NSE1515.702.4 (+0.16 %)
PREV CLOSE() 1513.30
OPEN PRICE () 1521.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1515.70 (3391)
VOLUME 435659
TODAY'S LOW / HIGH() 1492.10 1599.00
52 WK LOW / HIGH ()662.45 1577.5
BSE NSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 2017

Management Info :

Sanjay Shaileshbhai Majmudar - Chairman Swapnil Jatinbhai Shah - Managing Director

Registered Office :

Address : 1101 To 1103, 11th Floor, South Tower,One 42 Opp. Jayantilal Park,Ambali Bopal Road,
Ahmedabad,
Gujarat-380054

Phone : 079-29999857

Registrar's Details : MUFG Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE
NEWS
03Jul Senores Pharmaceuticals informs about
Pursuant to Regulation 30 and 47 of the Securities and Exchange Board of..
20May Senores Pharmaceuticals informs about
Pursuant to Regulation 30(6) read with Schedule III of the Securities an..
15May Senores Pharmaceuticals informs about
Senores Pharmaceuticals has informed regarding copy of Newspaper Publica..
04Apr Senores Pharmaceuticals informs about
Pursuant to Regulation 30 of the Securities and Exchange Board of India..
09Mar Senores Pharmaceuticals informs about
Pursuant to Regulation 30(6) read with Schedule III of the Securities an..
Financials
in Millions
QTR Jun 26 ANNUAL 26
Net Profit10.3202.5
Gross Profit 13.9 274.6
Operating Profit 72.2476.7
Net Sales 269.91060.9
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Abbott India (BSE)
 26450.00 (0.78%)
M.Cap ( in Cr)
56140.66
Kwality Pharma (BSE)
 3450.00 (2.77%)
M.Cap ( in Cr)
3604.54
Glenmark Pharma. (BSE)
 2386.60 (3.50%)
M.Cap ( in Cr)
67355.74
Shilpa Medicare (BSE)
 857.00 (5.22%)
M.Cap ( in Cr)
16761.36
Makers Laboratories (BSE)
 222.90 (20.00%)
M.Cap ( in Cr)
131.52
Shareholding Pattern
PROMOTERS 45.82%
NON-INSTITUTION 37.79%
MUTUAL FUNDS/UTI 6.56%
FI/BANKS/INSURANCE 1.62%
GOVERNMENT 0%
FII 0%
Mf Holding
ATTENTION INVESTORS

Kalpataru Multiplier Ltd.

Kalpataru is a wishful Divine Tree and in present context a widely Trusted, Time tested and Transparent Share Broker, Mutual Fund Distributor and D.P. of this region.

Mobile Trading App
Mobile Trading IOS App
Call Us 0755-4350141/142/143, 9425008895
Mutual Funds 0755-4276725, 4276726
Email Uskmlho@kalpatarumulti.com

registration nos:

Kalpataru Multiplier Ltd.: SEBI Regn. No. INZ000259437

Registered address: Kalpataru House, 18 Itwara, Bhopal (MP) – 462001

Member Member ID
Bombay Stock Exchange Ltd.(BSE) 3016
National Stock Exchange Ltd. 11152
Multi Commodity Exchange(MCX) 16020

Depository Participant of CDSL DP-ID 12031600

(SEBI Regn No. IN-DP-CDSL-221-2003)

In absence of response/ complaint not addressed to your satisfaction, you may lodge a complaint and reach out to us on:

SMART ODR PORTAL @ https://smartodr.in/login

Copyright © 2016 Kalpataru Multiplier Ltd.
Designed ,Developed & Content Powered by ●●● Accord Fintech Pvt. Ltd.
SENSEX77369.11-171.72 (-0.22%)
NIFTY24219.05-32.95 (-0.14%)
Dow Jones 53277.01517.80 (0.98%)
Nasdaq 26180.46113.29 (0.43%)
CLOSE Disclosure
CLOSE

INFORMATION UNDER THE HEAD SHOULD BE ADDED AS FOLLOWS

  • Sharing of trading credentials - login id & password including OTP's.
  • Trading in leveraged products like options without proper understanding, which could lead to losses.
  • Writing / selling options or trading in option strategies based on tips, without basic knowledge & understanding of the product and its risks.
  • Dealing in unsolicited tips through Whatsapp, Telegram, YouTube, Facebook, SMS, Calls, etc.
  • Trading in "Options" based on recommendations from unauthorised / unregistered investment advisors and influencers.
CLOSE SEBI